Drugs / Metaraminol

Trials 6 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01108874 Nov 2009 → Aug 2010 hypotensive disorder Federal University of São Paulo Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01451060 Jun 2011 → Jun 2014 preeclampsia Instituto Materno Infantil Prof. Fernando Figueira Withdrawn No outcome recorded
Phase 43 trials
Phase 4 NCT05658692 Oct 2022 → Oct 2023 acute respiratory distress syndrome Second Affiliated Hospital, School of Medicine, Zhejiang University Unknown No outcome recorded
Phase 4 NCT05084599 May 2022 → Jan 2024 Peking University People's Hospital Completed No outcome recorded
Phase 4 NCT04991662 Oct → Dec 2021 Xuzhou Medical University Completed No outcome recorded
Phase not applicable1 trial
NCT02245191 Jul 2014 preeclampsia University of Sao Paulo General Hospital Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Metaraminol metaraminolNCT05658692
5

NCT02245191

NCT01108874

NCT04991662

NCT05084599

NCT01451060

Known as Metaraminol hydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL1201319
Known as Metaraminol tartrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1201319
Modality Small molecule CHEMBL1201319